"Effectiveness of first‐line cetuximab in wild‐type RAS metastatic colorectal cancer according to tumour BRAF mutation status from the EREBUS cohort"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Effectiveness of first‐line cetuximab in wild‐type RAS metastatic colorectal cancer according to tumour BRAF mutation status from the EREBUS cohort

Poor efficacy has been reported for patients with BRAF mutations for metastatic colorectal cancer (mCRC). Click to show full abstract

Poor efficacy has been reported for patients with BRAF mutations for metastatic colorectal cancer (mCRC).

Keywords: metastatic colorectal; first line; colorectal cancer; effectiveness first; line cetuximab

Journal Title: British Journal of Clinical Pharmacology
Year Published: 2020

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended